Connor, Clark & Lunn Investment Management (CC&L)’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-21,219
| Closed | -$9.49M | – | 1650 |
|
|
2025
Q3 | $9.49M | Buy |
21,219
+20,505
| +2,872% | +$9.84M | 0.03% | 425 |
|
|
2025
Q2 | $388K | Sell |
714
-52,789
| -99% | -$27.6M | ﹤0.01% | 1310 |
|
|
2025
Q1 | $26.5M | Buy |
53,503
+46,228
| +635% | +$25.6M | 0.12% | 148 |
|
|
2024
Q4 | $3.8M | Sell |
7,275
-15,841
| -69% | -$8.25M | 0.02% | 558 |
|
|
2024
Q3 | $11.4M | Buy |
+23,116
| New | +$10.8M | 0.06% | 248 |
|
|
2024
Q2 | – | Sell |
-4,165
| Closed | -$1.66M | – | 1524 |
|
|
2024
Q1 | $1.66M | Buy |
+4,165
| New | +$1.57M | 0.01% | 726 |
|
|
2023
Q3 | – | Sell |
-3,719
| Closed | -$1.27M | – | 1445 |
|
|
2023
Q2 | $1.27M | Buy |
+3,719
| New | +$1.13M | 0.01% | 724 |
|
|
2022
Q4 | – | Sell |
-45,008
| Closed | -$8.44M | – | 1323 |
|
|
2022
Q3 | $8.44M | Buy |
45,008
+6,951
| +18% | +$1.49M | 0.06% | 230 |
|
|
2022
Q2 | $7.64M | Sell |
38,057
-1,150
| -3% | -$270K | 0.05% | 238 |
|
|
2022
Q1 | $11.8M | Buy |
39,207
+28,652
| +271% | +$8.37M | 0.06% | 205 |
|
|
2021
Q4 | $3.79M | Sell |
10,555
-36,767
| -78% | -$12.6M | 0.02% | 390 |
|
|
2021
Q3 | $15.7M | Sell |
47,322
-72,378
| -60% | -$24.3M | 0.08% | 174 |
|
|
2021
Q2 | $36.7M | Sell |
119,700
-8,583
| -7% | -$2.41M | 0.19% | 104 |
|
|
2021
Q1 | $31.6M | Buy |
128,283
+65,175
| +103% | +$16.4M | 0.18% | 114 |
|
|
2020
Q4 | $17.2M | Buy |
63,108
+30,531
| +94% | +$7.58M | 0.1% | 153 |
|
|
2020
Q3 | $7.71M | Buy |
32,577
+17,055
| +110% | +$3.83M | 0.05% | 240 |
|
|
2020
Q2 | $2.95M | Sell |
15,522
-93,798
| -86% | -$16.8M | 0.02% | 388 |
|
|
2020
Q1 | $18M | Sell |
109,320
-13,200
| -11% | -$2.42M | 0.16% | 109 |
|
|
2019
Q4 | $24.1M | Sell |
122,520
-27,075
| -18% | -$5.07M | 0.17% | 107 |
|
|
2019
Q3 | $26.9M | Buy |
149,595
+37,200
| +33% | +$6.43M | 0.18% | 105 |
|
|
2019
Q2 | $19.7M | Buy |
112,395
+98,175
| +690% | +$16.8M | 0.13% | 123 |
|
|
2019
Q1 | $2.71M | Buy |
14,220
+3,000
| +27% | +$533K | 0.02% | 368 |
|
|
2018
Q4 | $1.79M | Buy |
11,220
+495
| +5% | +$83.9K | 0.01% | 436 |
|
|
2018
Q3 | $2.05M | Sell |
10,725
-48,675
| -82% | -$8.64M | 0.01% | 429 |
|
|
2018
Q2 | $9.47M | Buy |
59,400
+42,075
| +243% | +$6.42M | 0.05% | 221 |
|
|
2018
Q1 | $2.38M | Buy |
17,325
+375
| +2% | +$52.3K | 0.01% | 367 |
|
|
2017
Q4 | $2.06M | Buy |
16,950
+1,425
| +9% | +$178K | 0.01% | 416 |
|
|
2017
Q3 | $1.8M | Buy |
15,525
+3,825
| +33% | +$417K | 0.01% | 440 |
|
|
2017
Q2 | $1.22M | Sell |
11,700
-102,825
| -90% | -$9.88M | 0.01% | 466 |
|
|
2017
Q1 | $9.75M | Buy |
114,525
+36,000
| +46% | +$2.84M | 0.06% | 181 |
|
|
2016
Q4 | $5.53M | Buy |
78,525
+61,425
| +359% | +$4.52M | 0.04% | 235 |
|
|
2016
Q3 | $1.38M | Buy |
17,100
+9,900
| +138% | +$758K | 0.01% | 421 |
|
|
2016
Q2 | $529K | Buy |
7,200
+3,600
| +100% | +$253K | ﹤0.01% | 573 |
|
|
2016
Q1 | $240K | Buy |
+3,600
| New | +$223K | ﹤0.01% | 689 |
|
|
2015
Q4 | – | Sell |
-9,900
| Closed | -$506K | – | 838 |
|
|
2015
Q3 | $506K | Buy |
+9,900
| New | +$561K | ﹤0.01% | 521 |
|
|
2015
Q1 | – | Sell |
-5,400
| Closed | -$317K | – | 592 |
|
|
2014
Q4 | $317K | Sell |
5,400
-5,400
| -50% | -$301K | ﹤0.01% | 454 |
|
|
2014
Q3 | $554K | Buy |
+10,800
| New | +$536K | ﹤0.01% | 375 |
|
|
2014
Q1 | – | Sell |
-8,865
| Closed | -$402K | – | 724 |
|
|
2013
Q4 | $402K | Buy |
+8,865
| New | +$373K | ﹤0.01% | 538 |
|
Other funds holding ISRG
Connor, Clark & Lunn Investment Management (CC&L)'s ISRG Position: Q4 2025 in Review
Connor, Clark & Lunn Investment Management (CC&L) sold out of Intuitive Surgical (ISRG) in Q4 2025, closing a stake of 21,219 shares — an estimated $9.49M sold.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ISRG in Q4 2013 and held it in 38 quarters. The position peaked at $36.7M in Q2 2021. 2,415 funds tracked by Wall St. Rank hold ISRG as of Q4 2025.
- Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Intuitive Surgical position as of Q4 2025 after selling out during the quarter.
- Connor, Clark & Lunn Investment Management (CC&L) sold 21,219 Intuitive Surgical shares in Q4 2025, an estimated $9.49M.
- Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Intuitive Surgical in Q4 2013 and held it in 38 quarters.
- Connor, Clark & Lunn Investment Management (CC&L)'s Intuitive Surgical position peaked at $36.7M in Q2 2021.
- 2,415 funds tracked by Wall St. Rank held Intuitive Surgical as of Q4 2025.
Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2025, filed 10 Feb 2026.